Moa Fransson
Director/Board Member bij ENZYMATICA AB
Profiel
Moa Fransson is the founder of Bioflow Systems AB.
She is currently the Chief Executive Officer of Genagon Therapeutics AB and Director at Enzymatica AB.
She holds a doctorate degree from the University of Uppsala.
Actieve functies van Moa Fransson
| Bedrijven | Functie | Begin |
|---|---|---|
| ENZYMATICA AB | Director/Board Member | 01-05-2022 |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Chief Executive Officer | 01-12-2019 |
Eerdere bekende functies van Moa Fransson
| Bedrijven | Functie | Einde |
|---|---|---|
| Bioflow Systems AB | Founder | - |
Opleiding van Moa Fransson
| University of Uppsala | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENZYMATICA AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
| Bioflow Systems AB |
